Treco Douglas A bought CRISPR Therapeutics AG ($CRSP) shares on the open market once in the last year, for a total of $1.14 million. The most recent purchase occurred on August 6, 2025. This ranks 445th among nearly 5,000 individual insiders by purchase value, below the average of $1.46 million across about 3.3 transactions per insider. Treco Douglas A reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 6, 2025 | CRISPR Therapeutics AG | $CRSP | Treco Douglas A | Not found | P | Common Shares | 20000 | $57.03 | 22,000.0000 | 85,774,474 | 1000.00% | 0.02% |
| June 5, 2025 | CRISPR Therapeutics AG | $CRSP | Treco Douglas A | Not found | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 85,774,474 | 9999.99% | 0.02% |
| May 30, 2024 | CRISPR Therapeutics AG | $CRSP | Treco Douglas A | Not found | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | CRISPR Therapeutics AG | $CRSP | Treco Douglas A | Director | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 0 | 9999.99% | 0.00% |